These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24410815)

  • 1. Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.
    Clarke SJ; McCormick LM; Dutka DP
    Cardiovasc Diabetol; 2014 Jan; 13():12. PubMed ID: 24410815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide 1 and cardiac cell survival.
    Ravassa S; Zudaire A; Díez J
    Endocrinol Nutr; 2012 Nov; 59(9):561-9. PubMed ID: 23031433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
    Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DRG-TRPV1 upregulation in myocardial ischemia contributes to exogenous cardioprotection.
    Xu S; Xu Y; Cheng X; Huang C; Pan Y; Jin S; Xiong W; Zhang L; He S; Zhang Y
    J Mol Cell Cardiol; 2020 Jan; 138():175-184. PubMed ID: 31836538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection for percutaneous coronary intervention--reperfusion quality as well as quantity.
    Giblett JP; West NE; Hoole SP
    Int J Cardiol; 2014 Dec; 177(3):786-93. PubMed ID: 25453404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
    Ban K; Noyan-Ashraf MH; Hoefer J; Bolz SS; Drucker DJ; Husain M
    Circulation; 2008 May; 117(18):2340-50. PubMed ID: 18427132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia.
    Giblett JP; Clarke SJ; Dutka DP; Hoole SP
    JACC Basic Transl Sci; 2016 Jun; 1(4):267-276. PubMed ID: 30167515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic strategies for cardioprotection.
    Sluijter JP; Condorelli G; Davidson SM; Engel FB; Ferdinandy P; Hausenloy DJ; Lecour S; Madonna R; Ovize M; Ruiz-Meana M; Schulz R; Van Laake LW;
    Pharmacol Ther; 2014 Oct; 144(1):60-70. PubMed ID: 24837132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
    Wright EJ; Farrell KA; Malik N; Kassem M; Lewis AL; Wallrapp C; Holt CM
    Stem Cells Transl Med; 2012 Oct; 1(10):759-69. PubMed ID: 23197668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.
    Siraj MA; Mundil D; Beca S; Momen A; Shikatani EA; Afroze T; Sun X; Liu Y; Ghaffari S; Lee W; Wheeler MB; Keller G; Backx P; Husain M
    J Clin Invest; 2020 Mar; 130(3):1392-1404. PubMed ID: 31985487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway.
    Penna C; Tullio F; Femminò S; Rocca C; Angelone T; Cerra MC; Gallo MP; Gesmundo I; Fanciulli A; Brizzi MF; Pagliaro P; Alloatti G; Granata R
    J Cell Mol Med; 2017 Dec; 21(12):3670-3678. PubMed ID: 28744974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart.
    Aravindhan K; Bao W; Harpel MR; Willette RN; Lepore JJ; Jucker BM
    PLoS One; 2015; 10(6):e0130894. PubMed ID: 26098939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
    Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
    Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.
    Robinson E; Tate M; Lockhart S; McPeake C; O'Neill KM; Edgar KS; Calderwood D; Green BD; McDermott BJ; Grieve DJ
    Cardiovasc Diabetol; 2016 Apr; 15():65. PubMed ID: 27079193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease.
    Read PA; Khan FZ; Dutka DP
    Heart; 2012 Mar; 98(5):408-13. PubMed ID: 21561896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling.
    Andreadou I; Bibli SI; Mastromanolis E; Zoga A; Efentakis P; Papaioannou N; Farmakis D; Kremastinos DT; Iliodromitis EK
    Int J Cardiol; 2015 Apr; 184():140-151. PubMed ID: 25703422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.